Foot-and-Mouth Disease Virus Lacking the Leader Protein and Containing Two Negative DIVA Markers (FMDV LL3B3D A<sub>24</sub>) Is Highly Attenuated in Pigs
Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recomb...
Main Authors: | Michael Eschbaumer, Veronika Dill, Jolene C. Carlson, Jonathan Arzt, Carolina Stenfeldt, Peter W. Krug, John M. Hardham, Jacob E. Stegner, Luis L. Rodriguez, Elizabeth Rieder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/9/2/129 |
Similar Items
-
Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
by: Tinka Jelsma, et al.
Published: (2021-05-01) -
Evaluation of a commercial ELISA kit (IDEXX) to differentiate AI virus-infected poultry from AI-vaccinated poultry (DIVA)
by: F Talazadeh, et al.
Published: (2014-06-01) -
Aujeszky’s Disease and the Development of the Marker/DIVA Vaccination Concept
by: Thomas C. Mettenleiter
Published: (2020-07-01) -
Dual function of the hemagglutinin H5 fused to chicken CD154 in a potential strategy of DIVA against avian influenza disease: preliminary study
by: A.G. Pose, et al.
Published: (2015-09-01) -
Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency
by: John M. Hardham, et al.
Published: (2020-09-01)